Giovanni G Camici Selected Research

Giovanni G Camici Research Topics

Disease

33	Thrombosis (Thrombus) 12/2023 - 07/2006
19	Inflammation (Inflammations) 03/2024 - 11/2008
19	Atherosclerosis 01/2023 - 04/2008
17	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 04/2008
16	Stroke (Strokes) 03/2024 - 01/2013
11	Myocardial Infarction 03/2024 - 01/2007
11	Acute Coronary Syndrome 10/2023 - 10/2006
7	Necrosis 01/2022 - 07/2010
6	Ischemic Stroke 11/2022 - 12/2013
5	Heart Failure 03/2024 - 01/2019
5	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2023 - 01/2017
5	Atrial Fibrillation 01/2023 - 03/2017
5	Infarction (Infarctions) 01/2020 - 01/2007
5	Reperfusion Injury 01/2019 - 01/2013
4	Obesity 05/2024 - 02/2011
4	ST Elevation Myocardial Infarction 10/2023 - 01/2018
3	Body Weight (Weight, Body) 05/2024 - 03/2007
3	Type 2 Diabetes Mellitus (MODY) 05/2024 - 02/2011
3	Hyperglycemia 05/2024 - 03/2007
3	Hypercholesterolemia 12/2023 - 11/2008
3	Carotid Artery Thrombosis 01/2023 - 01/2018
3	Hemorrhage 01/2023 - 01/2019
3	Hypertension (High Blood Pressure) 01/2022 - 03/2009
3	Ischemia 01/2020 - 01/2019
3	Brain Injuries (Brain Injury) 01/2019 - 01/2013
3	Chronic Renal Insufficiency 01/2018 - 11/2014
2	Diabetic Angiopathies (Diabetic Angiopathy) 10/2023 - 03/2007
2	Diabetic Cardiomyopathies 09/2023 - 10/2019
2	Left Ventricular Dysfunction 09/2023 - 01/2023
2	Rheumatoid Arthritis 01/2022 - 07/2014
2	Atherosclerotic Plaque (Atheroma) 01/2021 - 12/2018
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2021 - 03/2014
2	Vascular Remodeling 01/2020 - 10/2013
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 11/2019 - 01/2019
2	Dyslipidemias (Dyslipidemia) 10/2019 - 01/2018
2	Pathologic Constriction (Stenosis) 12/2018 - 01/2015
2	Brain Ischemia (Cerebral Ischemia) 11/2018 - 01/2018
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 01/2013

Drug/Important Bio-Agent (IBA)

23	Thromboplastin (Tissue Factor)IBA 01/2023 - 10/2006
9	Proteins (Proteins, Gene)FDA Link 06/2022 - 03/2007
7	Sirtuin 1IBA 05/2024 - 01/2010
7	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 03/2007
6	alpha-Linolenic Acid (Linolenic Acid)IBA 01/2023 - 08/2011
6	oxidized low density lipoproteinIBA 01/2023 - 10/2014
6	SirtuinsIBA 11/2022 - 01/2010
6	CytokinesIBA 01/2022 - 01/2016
5	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2023 - 03/2014
5	LipidsIBA 12/2022 - 01/2019
4	Phosphotransferases (Kinase)IBA 01/2023 - 11/2008
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2022 - 11/2014
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 11/2008
4	Small Interfering RNA (siRNA)IBA 11/2019 - 01/2012
4	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2017 - 10/2009
4	Free RadicalsIBA 08/2014 - 04/2008
3	EnzymesIBA 12/2023 - 01/2010
3	Plasminogen Activator Inhibitor 1IBA 01/2023 - 11/2014
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2023
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2023 - 11/2014
3	trimethyloxamine (trimethylamine N-oxide)IBA 01/2023 - 01/2019
3	RNA (Ribonucleic Acid)IBA 01/2021 - 11/2019
2	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 01/2023
2	omega-Chloroacetophenone (Mace)IBA 03/2024 - 01/2021
2	alirocumabIBA 12/2023 - 01/2017
2	Proprotein Convertase 9IBA 12/2023 - 01/2017
2	CholesterolIBA 12/2023 - 01/2021
2	fibrin fragment D (D-dimer)IBA 01/2023 - 01/2021
2	LDL CholesterolIBA 01/2023 - 12/2022
2	LipopolysaccharidesIBA 01/2023 - 01/2018
2	AnticoagulantsIBA 01/2023 - 01/2015
2	docosapentaenoic acidIBA 01/2023 - 02/2021
2	Docosahexaenoic AcidsIBA 01/2023 - 02/2021
2	Plasminogen InactivatorsIBA 01/2023 - 07/2010
2	Eicosapentaenoic AcidIBA 01/2023 - 02/2021
2	CollagenIBA 01/2023 - 01/2022
2	Matrix Metalloproteinases (MMPs)IBA 01/2023 - 11/2021
2	CalciumIBA 12/2022 - 07/2017
2	C-Reactive ProteinIBA 11/2022 - 11/2019
2	PCSK9 InhibitorsIBA 01/2022 - 01/2017
2	LectinsIBA 01/2022 - 04/2017
2	SubtilisinIBA 01/2022 - 01/2021
2	Class E Scavenger Receptors (Lectin Like Oxidized Low Density Lipoprotein Receptor 1)IBA 01/2022 - 11/2019
2	canakinumab FDA Link 01/2021 - 10/2018
2	OccludinIBA 01/2021 - 01/2018
2	Sirtuin 3IBA 01/2020 - 01/2018
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 01/2013
2	ChemokinesIBA 01/2019 - 01/2016
2	Mitogen-Activated Protein Kinase 9IBA 11/2017 - 11/2008
2	TicagrelorIBA 03/2017 - 01/2017
2	Clopidogrel (Plavix)FDA Link 03/2017 - 01/2017
2	SmokeIBA 01/2017 - 07/2014
2	Oxidants (Oxidizing Agents)IBA 02/2015 - 04/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014 - 07/2010
2	Thrombin FDA Link 05/2012 - 07/2010

Therapy/Procedure

10	Therapeutics 12/2022 - 02/2009
7	Stents 12/2023 - 07/2006
5	Drug-Eluting Stents 03/2014 - 07/2006
4	Lasers (Laser) 01/2023 - 11/2014
2	Percutaneous Coronary Intervention 12/2023 - 10/2023
2	Intravenous Injections 01/2021 - 01/2019
2	Ligation 01/2020 - 01/2007